Evidence map›Paper›PMID 37577076›Full record

ArticleRadiology case reports2023

Pure mediastinal seminoma about a case report.

Meriem Bouabid, Mohamed Moukhlissi, Ahmed Bensghir, Soumya Samba, Soufiane Berhili, Loubna Mezouar

Open access · goldAbstract readCase Reports
In one paragraph

Article in Radiology case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Meriem BouabidDepartment of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco.
Mohamed MoukhlissiDepartment of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco.
Ahmed BensghirDepartment of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco.
Soumya SambaDepartment of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco.
Soufiane BerhiliDepartment of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco.
Loubna MezouarDepartment of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco.
Mohamed I University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mediastinal Seminoma is one of the malignant germ cell tumors of the mediastinum. It is a rare tumor that represents only 1%-4% of mediastinal tumors. We report the case of a patient treated at the Oncology Center of Oujda for a pure primitive seminoma of the mediastinum, with a review of the literature to assess the epidemiological, clinical, therapeutic, and prognostic characteristics of this pathology. This is a 25-year-old man whose aunt is being treated for breast cancer and who complained of persistent dry cough with asthenia without any other associated signs. The initial imaging revealed a voluminous locally advanced tumor process in the anterior and middle mediastinum. Tumor markers Alpha-fetoprotein (AFP) and beta-subunit of chorionic gonadotrophic hormone (BHCG) were normal, as well as testicular ultrasound. The CT- guided transthoracic biopsy with anatomopathological study and immunohistochemistry was in favor of a pure seminoma. The treatment consisted of primary chemotherapy with BEP protocol. The response was favorable with a significant reduction in tumor size estimated at 90%. The residual tumor was inoperable due to its intimate contact with the vascular structures and was treated with external radiotherapy at a total dose of 36 Gy. The evolution at 20 months after treatment was in favor of a good clinical and radiological evolution.

Indexed as

ChemotherapyMediastinal seminomaPrognosisRadiotherapy

Identifiers

PMID37577076
PMCPMC10412719
OpenAlexW4385472948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.